
PRISMA—efficacy and safety of lixisenatide for type 2 diabetes mellitus
Author(s) -
Zhengang Wei,
Mancai Wang,
Huihan Zhang,
Zheyuan Wang,
Wang Gennian,
Fengying Wei,
Yawu Zhang,
Xiaodong Xu,
Youcheng Zhang
Publication year - 2018
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000013710
Subject(s) - lixisenatide , medicine , cochrane library , placebo , confidence interval , randomized controlled trial , adverse effect , type 2 diabetes mellitus , relative risk , meta analysis , postprandial , diabetes mellitus , type 2 diabetes , endocrinology , exenatide , alternative medicine , pathology